KRT18 and COVID-19: Arce and Costoya (2021) further investigated the usefulness and limitations of the k18-hACE2 model and found that extrapulmonary infection symptoms manifest in a mild manner due to the high concentration of ACE2 receptors in lung tissue, and thus would not be useful in understanding the severe clinical symptoms that can be seen in COVID-19 patients.